Wednesday, September 29, 2010

Egypt: Vaccine Will Be Made in China

September 29, 2010

Dr. Ahmed Snoussi, Professor of Virology Faculty of Veterinary Medicine, Cairo University, Egypt needs at least 20 years to eradicate the bird flu virus, pointing out that Egypt has become one of the areas "hot" of the disease.

And detect international expert in a special statement for the "seventh day" that Egypt became a state settlement of the disease, it is the only Africa that is located by the bird flu, and expected to see a winter this year and widespread of the disease, especially as there are rural areas are still areas of breeding for birds living .

And the vaccine reached by scholars of the Faculty of Veterinary Medicine in collaboration with the lab, "Harbin" Chinese denounced Sanusi, a member of the scientific team, the government's delay in the manufacture of this vaccine Egypt, pointing out that the Scientific Committee of veterinary services, the Supreme Committee to Combat Bird Flu Ojazata expired vaccine for use in Egypt.

He is Professor of viruses, the vaccine in Egypt has been manufactured in collaboration with the laboratory Harbin of China, was tested in China and has proved its efficiency for use, he said, adding, Minister of Agriculture adopted a 40 million pounds for the manufacture of a vaccine Egyptian to combat the disease, and that the minister has issued strict instructions to quickly manufactured, what the cause of the slowdown in the manufacture of the vaccine.

For his part, explains Dr. Rifaat Bebawy, commercial agent for plant Harbin China, Egypt The vaccine will be manufactured in Egypt, but he will make in China, to be imported from China again.

And the reasons which prevent the manufacture of the vaccine in Egypt, said Bebawy that Egypt does not have the possibility of manufacturing the vaccine, although the possession factor but research just can not manufacture the vaccine commercially, and said, "Egypt needs 500 thousand bottles of the vaccine every 7 months can not be produced in research labs. "

No comments: